The epidemiology and genetics of vitiligo

Clinics in Dermatology

Volumn 15, Issue 6, 1997, Pages 875-878

  Nordlund, James J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FAMILY HISTORY; HEREDITY; HUMAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; VITILIGO;

EID: 0030728590     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(97)00128-4     Document Type: Article

References (42)

1. Mehta NR, Shah KC, Theodore C, et al. Epidemiological study of vitiligo in Surat area, South Gujarat. Indian J Med Res 1973;61:145-54.
2. Das SK, Majumder PP, Chakraborty R, et al. Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 1985;2:71-8.
3. Howitz J, Brodthagen H, Schwartz M, and Thomsen K. Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977;113:47-52.
4. Tripathi R, et al. Evaluation of MITE locus linkage to human vitiligo and osteopetrosis. Presented to Third Joint Clinical Genetics Meeting, 1995.
5. Stevenson CJ. Occupational vitiligo: Clinical and epidemiological aspects. Br ] Dermatol 1981;105(Suppl 21):51-6.
6. Sen S. Caeruloplasmin, copper and diseases. J Indian Med Assoc 1969;52:182-4.
7. Sehgal VN, Dube B. Secretion of blood group specific substances in saliva of vitiligo patients. A preliminary report. Br J Dermatol 1967;79:704-5.
8. Sehgal VN, Dube B. ABO blood groups and vitiligo. J Med Genet 1968;5:308-9.
9. Sehgal VN, Dube B. Secretory state in vitiligo. Dermatologica 1969;138:89-92.
10. Kareemullah L, Taneja V, Begum S, et al. Association of ABO blood groups and vitiligo. J Med Genet 1977;14:211-3.
11. Wasfi AI, Saha N, El Munshid HA, et al. Genetic association in vitiligo: ABO, MNSs, Rhesus, Kell and Duffy blood groups. Clin Genet 1980;17:415-7.
12. Orecchia G, Perfetti L, Malagoli P, et al. Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in northern Italian patients. Dermatology 1992; 185:123-7.
13. al-Fouzan A, al-Arbash M, Fouad F, et al. Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients. Euro ) Immunogenet 1995;22:209-13.
14. Finco O, Cuccia M, Martinetti M, et al. Age of onset in vitiligo: Relationship with HLA supratypes. Clin Genet 1991;39:48-54.
15. Ando I, Chi HI, Nakagawa H, and Otsuka F. Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol 1993;129:408-10.
16. Hafez M, Sharaf L, Abd el-Nabi SM. The genetics of \itiligo. Acta Derm Venereol 1983;63:249-51.
17. Das SK, Majumder PP, Majumdar TK, and Haldar B. Studies on vitiligo. II. Familial aggregation and genetics. Genet Epidemiol 1985;2:255-62.
18. Salomon T, Hadziselimovic R, Halepovic E. The heritabilitv of vitiligo. Hautarzt 1989;40:141-5.
19. Majumder PP, Das SK, Li CC. A genetical model for vitiligo. Am J Hum Genet 1988;43:119-25.
20. Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol 1993;129:994-8.
21. Nath SK, Majumder PP, Nordlund Jj. Genetic epidemiology of vitiligo: Multilocus recessivitv cross-validated. Am J Hum Genet 1994;55:981-90.
22. Lerner AB, Shiohara T, Boissy RE, et al. A mouse model for vitiiigo. J Invest Dermatol 1986;87:299-304.
23. Boissy RE, Moellmann GE, Lerner AB. Morphology of melanocytes in hair bulbs and eyes of vitiligo mice. Am I Pathol 1987;127:380-8.
24. Amornsiripanitch S, Barnes LM, Nordlund JJ, et ai. Immune studies in the depigmenting C57BL/Ler-vit/vit mice. An apparent isolated loss of contact hypersensitivity. I Immunol 1988;140:3438-45.
25. Lamoreux ML, Boissy RE, Womack JE, and Nordlund JJ. The vit gene maps to the mi (microphthalrnia) locus of the laboratory mouse. J Hered 1992;83:43-9.
26. Hodgkinson CA, Moore KJ, Nakayama A, et ai. Mutations at the mouse microphthalmia locus arc associated with defects in a gene encoding a novel basic-helix-loop-helixzipper protein. Cell 1993;74:395-404.
27. Hughes AE, Newton VE, Liu X, and Read A P. A gene for Waardenburg syndrome type 2 maps dost1 to the human homologue of the microphthalrnia gene at chromosome 3pl2-pl4.1. Nat Genet 1994;7(4):309-i:
28. Nobukuni Y, Watanabe A, Takeda K, et al. Analyses of loss-of-function mutations of the M1TF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A. Am J Hum Genet 1996p9:7h S3
29. Steingrimsson E, Moore KJ, Lamoreux ML, et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences [see comments]. Nat Genet iS)94;8:256-63.
30. Tachibana M, Perez-Jurado LA, Nakayama A, et al. Cloning of MITE, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum Viol Genet 1994;3:553-7.
31. Fassabehji M, Newton VE, Read AP Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITE) gene [see comments]. Nat Genet 1994;8:251-5
32. Fassabehji M, Newton VE, Liu XZ, ft ;ii. The invitational spectrum in Waardenburg syndromi-. Hum Mol Genet 1995;4:2131-7.
33. Van Camp G, Van Thienen MN, Handig i, et ai. Chromosome 13q deletion with Waardenburg syndrome: further evidence for a gene involved in neural crest Function on 13q. J Med Genet 1995;32:531.
34. Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type caused by mutations in the human microophthalmia'(MITF) gene' Nat Genet 1994;8:231-5.
35. Dereymaeker AM, Eryns JP, Ars I, et al. Retinitis pigmentosa, hearing loss and vitiligo: report of two oatients. Clin Genet 1989;35:387-9.
36. Bader PI, Biegel A, Epinette WW. and Nance WE. Vitiligo and dysgammaglobulinemia. A case report and family study- Clin Genet 1975;7:62-76.
37. Lison M, Kornbrut B, Feinstein A, et al. Progressive spastic paraparesis, vitiligo, premature graying, and distinct facial appearance: A new genetic syndrome in 3 sibs. Am I Med Genet 1981;9:351-7.
38. Butler MC, Hodes ME, Conneally I'M, et al. Linkage analysis in a large kindred with juitosomal dominant transmission of polyglandular autoimmune disease type II (Schmidt syndrome). Am J Med Genet 1984;18:61-5.
39. Goudie RB, Spence JC, MacKie R. Vitiligo patterns simulating autoimmune and rheumatic diseases. Lancet 1979; 2:393-5.
40. Goudie RB, Goudie DR, Dick HM, and Ferguson-Smith MA. Unstable mutations in vitiligo, organ-specific auto-immune diseases, and multiple endocrine adenoma/peptic-ulcer syndrome. Lancet 1980;2:285-7.
41. Goudie RB, Spence JC, and MacKie R. Vitiligo patterns simulating autoimmune and rheumatic diseases. Lancet 1979;2:393-5.
42. Goudie BM, Wilkieson C, Goudie RB. A family study of vitiligo patterns. Scot Med J 1983;28:338-42.